## **Core Concept**
Hairy cell leukemia (HCL) is a rare, chronic, and malignant neoplastic disorder characterized by the clonal proliferation of mature B lymphocytes. It is named for the hair-like projections on the surface of the malignant cells. The diagnosis and identification of HCL involve specific immunophenotypic markers.

## **Why the Correct Answer is Right**
The correct marker for hairy cell leukemia is **CD103**. CD103, also known as integrin αE, is a cell surface protein that is specifically expressed on the surface of hairy cell leukemia cells. It plays a role in the homing of these cells to specific sites, such as the bone marrow and spleen. CD103 is a key diagnostic marker that helps differentiate HCL from other types of lymphoproliferative disorders.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain B cell markers like CD19 and CD20 are expressed on HCL cells, they are not specific for HCL as they are common to many B cell malignancies and normal B cells.
- **Option B:** CD22 is another B cell marker that can be found on HCL cells but, like CD19 and CD20, it is not specific for HCL.
- **Option D:** CD25 (IL-2 receptor alpha chain) can be expressed on HCL cells but is not as specific or sensitive as CD103 for the diagnosis of HCL.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the diagnosis of hairy cell leukemia often involves the demonstration of **CD103 positivity** along with other specific markers like CD22, CD11c, and CD123. The presence of CD103 is particularly useful in distinguishing HCL from other B cell lymphoproliferative disorders like chronic lymphocytic leukemia (CLL) and mantle cell lymphoma.

## **Correct Answer:** .